Apixaban 2.5 mg Twice Daily: Who Qualifies?

The apixaban label reduces the AF dose to 2.5 mg twice daily when two of three criteria are met — age 80 or older, weight 60 kg or less, creatinine 1.5 mg/dL or higher. This page applies the rule and flags the cases where it does not apply.

Apixaban dose reduction — nonvalvular atrial fibrillationReduce to 2.5 mg twice daily when at least two of: age ≥ 80 years, weight ≤ 60 kg, serum creatinine ≥ 1.5 mg/dL. Source: apixaban US prescribing information (ELIQUIS).
Age (years)
Weight (kg)
Serum creatinine (mg/dL)
Sex (for Cockcroft-Gault CrCl)
5 mg twice daily
Standard dose — 0 of 3 criteria met
Criteria assessment
CriterionStatus
Age ≥ 80 yearsNot met
Weight ≤ 60 kgNot met
Serum creatinine ≥ 1.5 mg/dLNot met
Estimated creatinine clearance (Cockcroft-Gault): 73.7 mL/min. The label criteria use serum creatinine directly; CrCl is shown for supporting context only.
Clinical Guidance

For nonvalvular atrial fibrillation, apixaban is dosed at 5 mg twice daily. The dose is reduced to 2.5 mg twice daily when at least two of three criteria are present: age 80 years or older, body weight 60 kg or less, or serum creatinine 1.5 mg/dL or higher. Meeting only one criterion does not trigger reduction.

This calculator is an educational aid and does not replace clinical judgement. Confirm the current product label, review interacting medications and renal function, and individualise therapy before prescribing.

Advertisement

How to Use

Enter the values for the scenario you are assessing. The apixaban label reduces the AF dose to 2.5 mg twice daily when two of three criteria are met — age 80 or older, weight 60 kg or less, creatinine 1.5 mg/dL or higher. This page applies the rule and flags the cases where it does not apply. Use the apixaban dose reduction result to inform your calculation.

Frequently Asked Questions